CBD stocks are in right now. The market is heating up like never before, and sales are growing fast. The projection now is that the CBD market will double every year for at least three years from 2018. If that is the case, now would be the perfect time for investors to get involved in this booming space.
So who is king? What CBD stocks are reaching for the crown? Let’s check out two top dogs.
CBD Stocks Reaching for the Crown: The Current King
Charlotte’s Web Holdings (CSE:CWEB) (OTCQX:CWBHF)
The daddy of CBD stocks right now, Charlotte’s Web Holdings, is a leading name in this market. It helps that it is also the biggest CBD company by market share in the US and has a market cap of $1.55 billion USD.
With 300 acres of hemp planted last year alone, Colorado’s CWEB has its products available in over 3,680 retail stores across the US.
Charlotte’s Web Holdings’ output consists of pure CBD oils and capsules, with absolutely none of its line involving THC-based cannabis products. This is one of the reasons why CWEB is a trusted and experienced name; the company has been doing what it does best long before the recreational cannabis industry took off, and definitely long before the recent Farm Bill turned investors’ noses towards the burgeoning market.
This CBD stock has established itself as a force to be reckoned with. But alas, it doesn’t come cheap. A reliable play for investors, but one you will have to dish out the dosh for.
Continuing the climb, shares are currently selling for $16.94 USD and $22.50 CAD on the respective OTCQX and CSE exchanges. Both exchanges are seeing gains; 2.36% on the OTCQX and 4.60% on the CSE.
CBD Stocks Reaching for the Crown: The Current Challenger
CV Sciences (OTCQB:CVSI)
You can’t ignore a CBD-based company that is one of the fastest growing out there. CV Sciences is experiencing revenue growth up 137% year-over-year.
This CBD stock offers bang for your buck as it is much cheaper in comparison to CWEB. At $5.14 USD at the time of writing, CV Sciences’ price is even sweeter when you realize the company is earning 85% the revenue of CWEB.
And according to Seeking Alpha: “CV Sciences is able to generate nearly as much adjusted EBITDA as Charlotte’s Web.”
The company has a ways to go; with a market cap of only $483.80 million, CV Sciences is significantly smaller than CWEB. Investors may wonder if the company’s recent growth is down to systemic hype surrounding CBD in the US. It has yet to prove its success long-term and herein lies a risk.
But overall, the CVSI CBD stock offers attractive value for money if you want to get going in this sector without spending too much up front.
So here you have two hot CBD stocks to rack your brains over. What kind of investor are you? Do you like paying for a sure-thing, or do you want to back an underdog currently offering the best value for money?
Featured Image: Canva